Vitamin D3 supplementation and blood pressure: a meta-analysis
Hypertension is a chronic condition that can lead to renal disease, cardiovascular disease, stroke and mortality. Vitamin D plays an important role in regulation of calcium and bone homeostasis and associated with mortality, type 2 diabetes, metabolic syndrome, cardiovascular disease and renal disease. Previous cross-sectional and cohort studies have shown an inverse association between 25-hydroxyvitamin D concentration and blood pressure however, randomized clinical trials (RCTs) of vitamin D3 supplementation (VD3S) effects on blood pressure have generated inconsistent results. Consequently, a meta-analysis is required.
We aimed to evaluate the effect of VD3S on systolic and diastolic blood pressure in a meta-analysis. Literature searches of PubMed, Scopus, Ovid and Google scholar for publications in English were conducted up to April 2015. The following key words were used for studies pertinent to the study objectives: ((“Cholecalciferol”[Mesh] OR Vitamin D3 supplementation [title/abstract]) OR (vitamin d3[title/abstract] AND supplementation[title/abstract])) AND ((“Hypertension”[Mesh] OR “blood pressure”[Mesh]) OR (hypertens*[title/abstract])). RCTs which assessed the effect of VD3S on systolic and diastolic blood pressure were selected. Studies were eligible for inclusion if: a) the study design was a RCT, b) the intervention was oral VD3S, c) the outcomes of interest were SBP and DBP, d) the population of interest was adults (aged >18 years). Trials which compared VD3S vs. placebo, or used VD3S in combination with calcium vs. calcium, were included. We screened 700 published articles which passed the initial inclusion criteria, of those 30 studies with 41 arms (including 4744 participants) were included in the meta-analysis.
The forest plots for the effects of VD3S on SBP and DBP are presented in Figures 1 and 2. Overall there was no significant reduction in SBP (-0.68 mmHg, 95%CI: -2.19 to 0.84) and DBP (-0.57 mmHg, 95%CI: -1.36 to 0.22) after intervention. VD3S had no significant effect in changes of SBP and DBP from baseline between men and women. VD3S significantly reduced SPB by on average -1.51 mmHg and DBP by -1.10 mmHg in adults aged 50 years and older. There were significant reductions in SBP (-1.40 mmHg) and DBP (-1.17 mmHg) in those studies which used >800 IU/d. VD3S alone decreased SBP by -3.60 mmHg and DBP by -1.97 mmHg. However, VD3S in combination with calcium supplementation significantly elevated SBP by 3.64 mmHg and DBP by 1.71 mmHg. In studies with durations ≤6 months, SBP (-1.51 mmHg) and DBP (-1.23 mmHg) were significantly decreased. Daily use of VD3S significantly reduced SBP by -1.41 mmHg and DBP by -1.18 mmHg. VD3S significantly reduced SBP and DBP in healthy adults (-3.96 mmHg and -2.23 mmHg, respectively) and hypertensive patients (-3.47 mmHg and -1.67 mmHg, respectively). In contrast it significantly increased SBP and DBP in overweight/obese subjects by 3.91 mmHg and 1.82 mmHg, respectively. After exclusion of studies were conducted on obese and overweight subjects, VD3S significantly decreased SBP by -3.73 mmHg and DBP by -2.01 mmHg. Findings from meta-regression analysis showed that there was no relationship between changes in SBP and baseline SBP, age in years, dose of VD3S and duration of intervention. No significant relationships between changes in DBP and baseline DBP, age, dose of VD3S and duration of intervention were found. No publication bias was found among studies.
The overall results of our meta-analysis have indicated that VD3S has variable impact on hypertension. Daily VD3S with a dose >800 IU/d or during <6 months intervention can significantly reduce SBP and DBP. In addition VD3S had a significant hypotensive effect in healthy subjects and hypertensive patients. In contrast VD3S significantly increased SBP and DBP in overweight and obese subjects, and when provided along with calcium.
Mahdieh Golzarand 1, Sakineh Shab-Bidar 2, John R. Speakman 3,4, Kurosh Djafarian 1
1Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics,
Tehran University of Medical Sciences, Tehran, Iran
2Department of Community Nutrition, School of Nutritional Sciences and Dietetics,
Tehran University of Medical Sciences, Tehran, Iran
3Institute of Biological and Environmental Sciences, University of Aberdeen,
Aberdeen, Scotland, United Kingdom
4Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China
Effect of vitamin D3 supplementation on blood pressure in adults: An updated meta-analysis.
Golzarand M, Shab-Bidar S, Koochakpoor G, Speakman J R, Djafarian K
Nutr Metab Cardiovasc Dis. 2016 Aug
|High blood pressure is controlled more effectively by two… Hypertension, or high blood pressure (BP), is a major global public health problem, both because of how common it is and its correlation with cardiovascular disease. It has been identified…|
|A tutorial on randomized study designs for lifestyle… Unhealthy lifestyle behaviours such as an unhealthy diet, excessive energy intake, smoking, excessive alcohol use, physical inactivity and poor stress-coping behaviour can act as causal factors in the pathway of…|
|Post-prandial excretion of calcium is a risk factor for… Calcium stones are caused by the precipitation of calcium-oxalate and/or calcium-phosphate on the surface of a kidney papilla. High urinary concentration of lithogenic ions, calcium and oxalate or phosphate, and…|
|Melatonin reduces blood pressure and tunes up disrupted… The older we get the more likely our circadian rhythms are disrupted. For example, blood pressure not only tends to increase but as well become more irregular. Luckily, as we…|
|Visceral adiposity index as a potential biomarker for… Nowadays, obesity poses one of the greatest public health challenges worldwide. Visceral adiposity and its associated disorders including dyslipidemia, insulin resistance, diabetes and hypertension, are the key elements characterizing the…|
|Top ten research priorities relating to stroke nursing It is important that research addresses what is of greatest priority to people affected by a health condition. A UK based organisation called the James Lind Alliance (JLA) brings patients,…|